Overview
Beta-thalassemia-trichothiodystrophy syndrome is an extremely rare genetic condition that combines features of two distinct disorders: beta-thalassemia, a blood disorder, and trichothiodystrophy (TTD), a condition that primarily affects the hair, skin, and sometimes the nervous system. Patients with this syndrome have problems making enough healthy hemoglobin, the protein in red blood cells that carries oxygen throughout the body. This leads to anemia, which can cause tiredness, weakness, and pale skin. At the same time, the trichothiodystrophy component causes brittle hair that is sulfur-deficient, giving it a characteristic 'tiger tail' pattern under special microscopy. The hair breaks easily and may appear short and sparse. Some patients may also have dry, scaly skin (ichthyosis), sensitivity to sunlight, short stature, intellectual disability, and recurrent infections. Because this syndrome is so rare, the treatment landscape is limited and largely supportive. Management typically focuses on treating the anemia through blood transfusions and iron chelation therapy when needed, while also addressing skin and hair problems with moisturizers and sun protection. Developmental support and regular monitoring by multiple specialists are important parts of care. Research into the underlying genetic mechanisms continues, but no targeted therapy currently exists for this combined syndrome.
Key symptoms:
Anemia (low red blood cell count)Pale skinFatigue and weaknessBrittle, easily breakable hairShort and sparse hairDry, scaly skin (ichthyosis)Sensitivity to sunlightShort statureIntellectual disability or developmental delaysRecurrent infectionsAbnormal nailsReduced fertilityEnlarged spleen
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Infantile
Begins in infancy, roughly 1 month to 2 years old
Treatments
No FDA-approved treatments are currently listed for Beta-thalassemia-trichothiodystrophy syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Beta-thalassemia-trichothiodystrophy syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Beta-thalassemia-trichothiodystrophy syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Beta-thalassemia-trichothiodystrophy syndrome.
Community
No community posts yet. Be the first to share your experience with Beta-thalassemia-trichothiodystrophy syndrome.
Start the conversation →Latest news about Beta-thalassemia-trichothiodystrophy syndrome
No recent news articles for Beta-thalassemia-trichothiodystrophy syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.How severe is my child's beta-thalassemia, and will they need regular blood transfusions?,What specific genetic mutations were found, and what do they mean for my child's outlook?,What sun protection measures are most important, and should we avoid certain activities?,Are there developmental therapies that should be started early to help my child?,How often should blood counts and iron levels be monitored?,Is bone marrow transplant or gene therapy an option for my child?,Are there other family members who should be tested as carriers?
Common questions about Beta-thalassemia-trichothiodystrophy syndrome
What is Beta-thalassemia-trichothiodystrophy syndrome?
Beta-thalassemia-trichothiodystrophy syndrome is an extremely rare genetic condition that combines features of two distinct disorders: beta-thalassemia, a blood disorder, and trichothiodystrophy (TTD), a condition that primarily affects the hair, skin, and sometimes the nervous system. Patients with this syndrome have problems making enough healthy hemoglobin, the protein in red blood cells that carries oxygen throughout the body. This leads to anemia, which can cause tiredness, weakness, and pale skin. At the same time, the trichothiodystrophy component causes brittle hair that is sulfur-defi
How is Beta-thalassemia-trichothiodystrophy syndrome inherited?
Beta-thalassemia-trichothiodystrophy syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Beta-thalassemia-trichothiodystrophy syndrome typically begin?
Typical onset of Beta-thalassemia-trichothiodystrophy syndrome is infantile. Age of onset can vary across affected individuals.